Response (ASPR) at the US Department of Health and Human Services (HHS) said officials are moving forward with a plan to produce 4.8 million doses of H5N1 avian flu vaccine for pandemic preparedness. Dawn O'Connell, JD, said health officials have identified a manufacturing line at one of its manufacturing partners for fill-and-finish steps, without disrupting production of seasonal flu vaccine. Currently, the vaccine is in bulk form and will be produced in multidose vials. She said it takes a couple months to fill and finish the vaccine doses, which would save time in case a vaccine is needed. Federal health...